Apatinib combined with camrelizumab in advanced acral melanoma patients: An open-label, single-arm phase 2 trial.
European journal of cancer (Oxford, England : 1990)（2023）
Key words
Acral melanoma,Anti-PD-1 antibody,Apatinib,Immunotherapy
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined